Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
BARTHEL NOSBÜSCH INH. JÜRGEN BALLING Address & Contact
Website
BARTHEL NOSBÜSCH at a Glance
BARTHEL NOSBÜSCH, managed by Jürgen Balling, is a sole proprietorship based in Düsseldorf, North Rhine-Westphalia, that operates in the field of medical technology. With a strong focus on regional needs, the company offers a variety of products and services for medical facilities as well as the healthcare sector. Düsseldorf, as a significant economic and healthcare location along the Rhine, plays a central role in the local medical technology industry. The company is characterized by its many years of experience and in-depth knowledge of the market, enabling it to successfully cater to the needs of local customers.
Services and Products
BARTHEL NOSBÜSCH offers a wide range of medical technology products and services specifically tailored to the requirements of medical practices and clinics in the Düsseldorf region. These include:
- Diagnostic Techniques: Modern devices for precise diagnostics that meet the latest technological standards.
- Therapeutic Devices: Innovative therapy solutions to support patients during treatment.
- Accessories and Consumables: High-quality medical accessories that ensure smooth patient care.
- Consultation and Training: Individual consulting services and training for medical professionals to ensure the efficient use of the products.
The company takes particular pride in its individual customer care and the regional availability of products. Thanks to personal communication and attention to specific requirements, customers in the Düsseldorf region benefit from customized solutions that address the unique challenges of everyday medical practice.
Regulatory Classification
BARTHEL NOSBÜSCH operates in a highly regulated market. The medical technology products are subject to the regulations of the European Medical Device Regulation (MDR). This ensures that all products offered meet the highest quality standards and are both safe and effective in use. These regulatory requirements are crucial for customer trust and market acceptance of the products. The company places great importance on the continuous training of its employees regarding current legal changes and new developments in medical technology.
Regional Significance
Düsseldorf is not only the state capital of North Rhine-Westphalia but also a significant center for medical technology and healthcare provision. The University Hospital Düsseldorf (UKD), numerous specialized clinics, and research institutions create a dynamic market in which BARTHEL NOSBÜSCH plays an important role. Through close collaboration with these institutions, the company can respond to the latest developments and trends in the industry and adjust its product range accordingly.
Another point that emphasizes the regional importance of BARTHEL NOSBÜSCH is the targeted promotion of innovation projects. Through partnerships with local universities and research institutions, the company works on developing new technologies and treatment methods that aim to sustainably improve healthcare in the region.
Special Features of the Company
BARTHEL NOSBÜSCH stands out from other medical technology companies due to several unique characteristics. Close customer relationships are a key to their success. Jürgen Balling and his team take the time to understand the specific needs of their customers and provide tailored solutions. This is reflected in the high customer satisfaction and the long-term relationships established with many medical institutions in the region.
Another aspect is the company's readiness to respond to current challenges in healthcare. Given the increasing demands on healthcare due to demographic changes, BARTHEL NOSBÜSCH is committed to finding innovative approaches to continuously improve patient care.
More medical technology companies: Overview of Medical Technology | Sanitary Facilities | Nursing Homes
Frequently asked questions about BARTHEL NOSBÜSCH INH. JÜRGEN BALLING
What does BARTHEL NOSBÜSCH INH. JÜRGEN BALLING do?
BARTHEL NOSBÜSCH INH. JÜRGEN BALLING is a company in the medical technology sector based in Düsseldorf. The company develops, manufactures or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is BARTHEL NOSBÜSCH INH. JÜRGEN BALLING based?
BARTHEL NOSBÜSCH INH. JÜRGEN BALLING is based in Düsseldorf. Detailed information can be found on the company website.
In which area of medical technology does BARTHEL NOSBÜSCH INH. JÜRGEN BALLING operate?
BARTHEL NOSBÜSCH INH. JÜRGEN BALLING operates in the medical technology sector and offers solutions for healthcare facilities, hospitals and practices. The exact areas of activity can be found on the company website.
More Medical Technology in Düsseldorf
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.